No abstract available
Publication types
-
Letter
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Adult
-
B-Lymphocytes / immunology
-
B-Lymphocytes / virology
-
Betacoronavirus / immunology*
-
Betacoronavirus / pathogenicity
-
CD4-Positive T-Lymphocytes / immunology*
-
CD4-Positive T-Lymphocytes / virology
-
CD8-Positive T-Lymphocytes / immunology*
-
CD8-Positive T-Lymphocytes / virology
-
COVID-19
-
Case-Control Studies
-
Coronavirus Infections / diagnostic imaging
-
Coronavirus Infections / immunology*
-
Coronavirus Infections / mortality
-
Coronavirus Infections / virology
-
Disease Progression
-
Female
-
Humans
-
Interleukin-10 / blood
-
Interleukin-10 / immunology
-
Interleukin-6 / blood
-
Interleukin-6 / immunology
-
Killer Cells, Natural / immunology
-
Killer Cells, Natural / virology
-
Lung / diagnostic imaging
-
Lung / immunology*
-
Lung / virology
-
Lymphocyte Count
-
Male
-
Middle Aged
-
Pandemics
-
Pneumonia, Viral / diagnostic imaging
-
Pneumonia, Viral / immunology*
-
Pneumonia, Viral / mortality
-
Pneumonia, Viral / virology
-
Prognosis
-
Proteoglycans
-
SARS-CoV-2
-
Severity of Illness Index
-
Survival Analysis
-
Tomography, X-Ray Computed
-
beta-Glucans / blood
-
beta-Glucans / immunology
Substances
-
IL10 protein, human
-
IL6 protein, human
-
Interleukin-6
-
Proteoglycans
-
beta-Glucans
-
Interleukin-10
-
polysaccharide-K